Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Metadata
Title
The G1359A-CNR1 gene polymorphism is associated to glioma in Spanish patients
Authors
Mercedes Núñez
Sandra Perdomo
Juan Moreta
Ángel Santos-Briz
Rogelio González-Sarmiento
Publication date
01-12-2010
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 12/2010
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-010-0604-7

Other articles of this Issue 12/2010

Clinical and Translational Oncology 12/2010 Go to the issue

Special Article

Professional survey on knowledge and clinical patterns of pain management in Spanish medical oncology

Research Articles

Computed tomography (CT) predicts accurately the pathologic tumour size in stage I non-small-cell lung cancer (NSCLC)

Editorial

The role of the radiation oncologist in oncology today

Education Alseries/Green Series

Treatment of high-risk neuroblastoma with anti-GD2 antibodies

Educational Series/Blue Series

Classification of ovarian carcinomas based on pathology and molecular genetics

Educational Series/Purple Series

Multidisciplinary management in rectal cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits